สืบค้นงานวิจัย
Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
Wasitthankasem R. - ไม่ระบุหน่วยงาน
ชื่อเรื่อง (EN): Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
ผู้แต่ง / หัวหน้าโครงการ (EN): Wasitthankasem R.
บทคัดย่อ (EN): The prevalence of hepatitis C virus (HCV) infection has been decreasing globally, but the growing effects of HCV-related morbidity and mortality remain of concern. Advances in curative medicine, involving direct-acting antivirals (DAAs), have led many countries to aim to eradicate HCV. Information on epidemiology and disease burden is essential for national policy development. Thus, this study aimed to determine the HCV-related hepatic disease burden in areas of Thailand with high and average HCV prevalence in order to extrapolate the viral burden across Thailand. Patients previously diagnosed as positive for anti-HCV antibodies were recruited to assess chronic HCV infection (CHC) status, liver function, HCV-RNA level and hepatic fibrosis. The number of patients eligible for Universal Health Coverage (UC) scheme and the approximately required expenditure on interferon (IFN)based treatment were estimated. In areas of both high (12%) and average (2%) HCV viremic prevalence, over half of the patients (52.2% to 62.5%) had advanced liver fibrosis (F3 and F4). A striking percentage of patients with F4 (38.9%) were found in the high-prevalence area, while comparable proportions of advanced liver fibrosis presented in the two areas and disease burden peaked at 50–59 years. Under the current UC program treatment scenario, 78–83% of CHC patients with stage F2–F4 fibrosis were eligible for treatment. The estimated expenditure required for overall CHC treatment across the whole country was 1,240 million USD at this current status, but the declining cost of generic DAA-based therapy may reduce the requirement to <90 million USD. This study provides information on the estimated number of CHC patients, liver disease burden and expenditure requirements for Thailand. To eliminate HCV by 2030, proactive government strategies raising public health to minimize transmission and emphasizing targeted screen-and-treatment programs, novel therapeutic guideline development for decentralizing treatment, and effective budget allocation are urgently needed. © 2018 Wasitthankasem et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
บทคัดย่อ: ไม่พบข้อมูลจากหน่วยงานต้นทาง
ภาษา (EN): en
เอกสารแนบ (EN): https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045939717&doi=10.1371%2fjournal.pone.0196301&partnerID=40&md5=9b99d13f995c37769202f70031c8c0fe
เผยแพร่โดย (EN): มหาวิทยาลัยมหิดล
คำสำคัญ (EN): Young Adult
เจ้าของลิขสิทธิ์ (EN): มหาวิทยาลัยมหิดล
หากไม่พบเอกสารฉบับเต็ม (Full Text) โปรดติดต่อหน่วยงานเจ้าของข้อมูล

การอ้างอิง

Wasitthankasem R.. "Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study". ไม่ระบุหน่วยงาน. ม.ป.ป.

Wasitthankasem R.. "Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study". ไม่ระบุหน่วยงาน. ม.ป.ป.. Print.



TARR Wordcloud:
Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study
Wasitthankasem R.
มหาวิทยาลัยมหิดล
ไม่ระบุวันที่เผยแพร่
Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand A new variety of Cryptocoryne crispatula Engl. (Araceae) from Thailand Appropriate option of market solid waste management based on the stakeholder perspectives: A case study in a central market of agriculture products, Thailand Spatial distribution of forensically significant blow flies in subfamily luciliinae (Diptera: Calliphoridae), Chiang Mai province, northern Thailand: Observations and modeling using GIS Four new species of begonia (begoniaceae) from Thailand The Diachasmimorpha longicaudata complex in Thailand discriminated by its wing venation: Reference-based morphometric identification Revision of Bruchomyiinae (Diptera, Psychodidae) of the Oriental Region, with description of a new genus and species and discussion of putative male/female antagonistic coevolution Emergence of tilapia lake virus in Thailand and an alternative semi-nested RT-PCR for detection Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy Association of Sjögrens syndrome in patients with chronic hepatitis virus infection: A population-based analysis
คัดลอก URL
กระทู้ของฉัน
ผลการสืบค้นทั้งหมด โพสต์     เรียงลำดับจาก
พัฒนาระบบโดยศูนย์ความรู้เฉพาะด้านวิศวกรรมความรู้และวิศวกรรมภาษาDeveloped by Center of Excellence for Unified Knowledge and Language Engineering
สนับสนุนโดยสำนักงานพัฒนาการวิจัยการเกษตร (องค์การมหาชน)Supported by the Agricultural Research Development Agency (Public Organization)
แบบสำรวจความพึงพอใจQuestionair